Embecta Corp. (EMBC)
5.685
-0.06
(-1.13%)
USD |
NASDAQ |
Oct 09, 16:00
5.75
+0.06
(+1.14%)
After-Hours: 20:00
Embecta Cash from Investing (Quarterly) : -129.50M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -129.50M |
| March 31, 2026 | -0.50M |
| December 31, 2025 | 9.50M |
| September 30, 2025 | -7.30M |
| June 30, 2025 | -0.40M |
| March 31, 2025 | -0.10M |
| December 31, 2024 | -1.50M |
| September 30, 2024 | 0.00 |
| June 30, 2024 | -9.70M |
| March 31, 2024 | -3.40M |
| December 31, 2023 | -2.70M |
| Date | Value |
|---|---|
| September 30, 2023 | -9.20M |
| June 30, 2023 | -6.80M |
| March 31, 2023 | -5.80M |
| December 31, 2022 | -4.70M |
| September 30, 2022 | -8.60M |
| June 30, 2022 | -5.30M |
| March 31, 2022 | -5.80M |
| December 31, 2021 | -4.30M |
| September 30, 2021 | -13.10M |
| June 30, 2021 | -7.70M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Artivion, Inc. | -129.41M |
| Abbott Laboratories | -673.00M |
| AngioDynamics, Inc. | -3.148M |
| Alphatec Holdings, Inc. | -22.72M |
| AtriCure, Inc. | -3.766M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 41.80M |
| Cash from Financing (Quarterly) | 112.40M |
| Free Cash Flow | 164.60M |
| Free Cash Flow Per Share (Quarterly) | 0.6956 |
| Free Cash Flow to Equity (Quarterly) | -88.50M |
| Free Cash Flow to Firm (Quarterly) | 58.97M |
| Free Cash Flow Yield | 49.08% |